Fairvalue-Calculator Fairvalue-Calculator
EN DE

HealthEquity, Inc (HQY) Fair Value & Analysis

Healthcare · US · Market cap $7.4B

Price$84.92
Fair Value$56.63
Upside-33.3%
Quality97/100
Evidence: High Range $42.47 – $70.79

Analysis

HealthEquity, Inc (HQY) currently trades at $84.92, while our model-based Fair Value estimate is $56.63 — implying the stock looks roughly 33.3% overvalued today. We read business quality at 97/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Open the full interactive analysis →

Similar stocks

Veeva Systems Inc (VEEV) -35% Pro Medicus Limited (PME) -83% BrightSpring Health Services, Inc (BTSG) -68% Tempus AI, Inc (TEM) -74% M3, Inc (MTHRY) +2% Hinge Health, Inc (HNGE) -56%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.